Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T25610 |
Lanabecestat camsylate
LY 3314814 camsylate,LY-3314814 camsylate,LY3314814 camsylate |
||
Lanabecestat camsylate is used as a BACE1 Inhibitor. | |||
TQ0238 |
Lanabecestat
LY3314814,AZD3293 |
BACE | Neuroscience |
Lanabecestat (AZD3293) 是一种具有高效性和高渗透性、口服活性且可穿过血脑屏障的 BACE1 抑制剂(Ki:0.4 nM),Lanabecestat 可用于研究像阿尔茨海默症类的神经系统疾病。 | |||
T10014 |
(1α,1'S,4β)-Lanabecestat
(1α,1'S,4β)-AZD3293 |
Others | Others |
(1α,1'S,4β)-Lanabecestat is a Beta site APP Cleaving Enzymel (BACE1) inhibitor, and has IC50s of 2.2 nM (TR-FRET assay) and 0.28 nM (sAPPp release assay), respectively. | |||
T70807 |
Lanabecestat HCl
|
||
Lanabecestat, also known as AZD3293 and LY3314814, is a potent, highly permeable, orally active, blood-brain barrier (BBB) penetrating, BACE1 inhibitor with unique slow off-rate kinetics. AZD3293 displayed significant dose- and time-dependent reductions in plasma, cerebrospinal fluid, and brain concentrations of Aβ40, Aβ42, and sAβPPβ. |